| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $0.6B | $0.5B | $1.7B | $1.4B | $0.8B | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $-0.0B |
| Net Income | $0.1B | $0.1B | $0.1B | $-0.0B | $-0.4B | $-0.0B |
| EPS (Basic) | $0.12 | $0.20 | $0.12 | $-0.02 | $-1.27 | — |
| EPS (Diluted) | $0.10 | $0.20 | $0.10 | $-0.02 | $-1.34 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $11.0B | $8.8B | $8.9B | $8.3B | $0.3B |
| Current Assets | — | — | — | — | — | $0.0B |
| Cash & Equivalents | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $6.4B | $5.2B | $3.5B | $3.3B | $2.4B | $0.0B |
| Current Liabilities | — | — | — | — | — | $0.0B |
| Stockholders' Equity | $2.2B | $2.1B | $1.5B | $1.6B | $1.7B | $0.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.3B | $1.0B | $0.9B | $0.7B | $0.3B | $-0.0B |
| Investing Cash Flow | $-0.3B | $-0.6B | $-0.1B | $-0.5B | $-1.6B | $-0.3B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | — |
| Financing Cash Flow | $-0.9B | $-0.3B | $-0.8B | $-0.2B | $1.3B | $0.3B |